Dr. Robert G. Keller, MD
ENT (Otolaryngology) (Otolaryngology Physician)
3030 N Circle Dr Ste 300
Colorado Springs, CO 80909
Who else practices at this address →
El Paso County is a federal mental health shortage area. About shortage areas
- Medicare participating
At a glance
- Medical school
- New York University School of Medicine (2013)
- Years since graduation
- 13
- In the NPI registry since
- 2013
- Medicare patients seen, 2024
- 493
Licensed in Colorado since 2018, according to the Colorado Department of Regulatory Agencies. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2013Medical school: New York University School of Medicine
- 2013Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Otolaryngology Physician primary
CO license 60346 (first issued 2018; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Centura Health-Penrose St Francis Health Services Colorado Springs, CO
- St Mary-Corwin Hospital Pueblo, CO
Medical groups
- Colorado Otolaryngology Associates, LLC (21 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 493
- Services billed
- 1,659
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 355 | 248 |
| Established patient office or other outpatient visit, 30-39 minutes | 164 | 127 |
| Diagnostic exam of nasal passages using an endoscope | 163 | 135 |
| New patient office or other outpatient visit, 45-59 minutes | 135 | 135 |
| New patient office or other outpatient visit, 30-44 minutes | 118 | 118 |
| Diagnostic exam of voice box using a flexible endoscope | 103 | 92 |
| Exam of ear using a microscope | 96 | 78 |
| Ct scan of face without contrast | 56 | 50 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 46 | 28 |
| Comprehensive hearing and speech recognition test | 46 | 46 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 8 companies reported 35 payments worth $17,610 in total to this clinician.
| Genzyme Corporation | $16,936 |
|---|---|
| AstraZeneca Pharmaceuticals LP | $208 |
| Medtronic, Inc. | $183 |
| Regeneron Healthcare Solutions, Inc. | $148 |
| Neurent Medical Limited | $58.30 |
| GlaxoSmithKline, LLC. | $31.06 |
| Amgen Inc. | $28.07 |
| Aerin Medical Inc. | $18.71 |
| Compensation for services other than consulting (speaking, faculty) | $14,144 |
|---|---|
| Consulting Fee | $1,344 |
| Travel and Lodging | $1,264 |
| Food and Beverage | $858 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Genzyme Corporation Sep 12, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT; DUPIXENT · Immunology | $8,736 |
| Genzyme Corporation Sep 12, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT; DUPIXENT · Immunology | $4,576 |
| Genzyme Corporation Jun 11, 2025 | Consulting Fee | $1,344 |
| Genzyme Corporation Sep 12, 2025 | Travel and Lodging DUPIXENT; DUPIXENT · Immunology · travel to Aspen, CO · in-kind | $944 |
| Genzyme Corporation Dec 10, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $832 |
| Genzyme Corporation Sep 12, 2025 | Travel and Lodging DUPIXENT; DUPIXENT · Immunology · travel to Aspen, CO | $321 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.